好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2012 Annual Meeting | Diagnosis and Management of Leukodystrophies

Friday 03/22/13
08:00 AM - 12:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
AM Half-Day Course
Adeline Vanderver, MD, FAAN
Participants should be able to understand newly characterized, as well as classical, inherited disorders of CNS myelin; and be able to recognize important clues from the clinical syndromes, patterns of inheritance, and a patient's imaging studies to generate an appropriate differential diagnosis and strategy for diagnostic testing for a patient with suspected leukodystrophy.
No CME available
Medical Knowledge
Trainee, General Neurologist, Specialist Neurologist
Case-based, Interactive, Audience Participation

Program Evaluations

Event Timeline
08:00 AM - 08:10 AM Introduction
Adeline Vanderver, MD, FAAN
08:00 AM - 12:00 PM
08:10 AM - 08:50 AM Update on the Diagnosis and Management of Adrenoleukodystrophy
Gerald Raymond, MD
08:50 AM - 09:00 AM Questions/Discussion
09:00 AM - 09:40 AM The Hypomyelinating Leukodystrophies—Established and Novel Disorders
Genevieve Bernard, MD
09:40 AM - 09:50 AM Questions/Discussion
09:50 AM - 10:05 AM Break
10:05 AM - 10:45 AM Adult Onset Heritable Leukoencephalopathies
Adeline Vanderver, MD, FAAN
10:45 AM - 10:55 AM Questions/Discussion
10:55 AM - 11:35 AM An Updated Diagnostic Algorithm in Leukodystrophies and Leukoencephalopathies
Raphael Schiffmann, MD, FAAN
11:35 AM - 12:00 PM Questions/Discussion and Audience Cases
Faculty Disclosures
Adeline Vanderver, MD, FAAN An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Gerald Raymond, MD Dr. Raymond has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Bluebird bio. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Travere. Dr. Raymond has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Dept of HHS.
Raphael Schiffmann, MD, FAAN No disclosure on file
Genevieve Bernard, MD Dr. Bernard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Calico. Dr. Bernard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Orchard Therapeutics. Dr. Bernard has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for N/A. The institution of Dr. Bernard has received research support from Canadian Institutes of Health Research. The institution of Dr. Bernard has received research support from Montreal Children's Foundation. The institution of Dr. Bernard has received research support from Yaya Foundation for 4H Leukodystrophy. The institution of Dr. Bernard has received research support from Fondation Les Amis d'Elliot. The institution of Dr. Bernard has received research support from Ionis. Dr. Bernard has a non-compensated relationship as a Member of the Scientific Advisory Board with Pelizaeus-Merzbacher Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Member of the Medical and Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Chair of the Medical and Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities. Dr. Bernard has a non-compensated relationship as a Member of the Scientific and Clinical advisory Council with Yaya Foundation that is relevant to AAN interests or activities.